NCT03289299 Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03287908 A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma Status TERMINATED Phase PHASE1
NCT03287609 EVOlocumab for Early Reduction of LDL-cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) Status COMPLETED Phase PHASE3
NCT03283098 A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416 Status COMPLETED Phase PHASE1
NCT03276728 Study to Evaluate the Safety and Tolerability of AMG 986 in Healthy Volunteers and Heart Failure Patients Status TERMINATED Phase PHASE1
NCT03263572 Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE2
NCT03256344 Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases Status COMPLETED Phase PHASE1
NCT03239145 Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor Status COMPLETED Phase PHASE1
NCT03238781 Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention Status COMPLETED Phase PHASE2
NCT03224819 Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML) Status TERMINATED Phase EARLY_PHASE1
NCT03224507 Monoclonal Antibody-Based Sequential Therapy for Deep Remission in Multiple Myeloma Status COMPLETED Phase PHASE2
NCT03182725 Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome Status COMPLETED Phase PHASE3
NCT03182699 Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients Status COMPLETED Phase PHASE4
NCT03168529 Trial Assessing the Effectiveness of Ivabradine Started at Discharge From the Observation Unit Status TERMINATED Phase PHASE4
NCT03164928 Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis Status COMPLETED Phase PHASE3
NCT03161756 Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma Status UNKNOWN Phase PHASE1/PHASE2
NCT03160079 Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts Status COMPLETED Phase PHASE1/PHASE2